Global Patent Index - EP 3893866 A4

EP 3893866 A4 20220803 - A COMBINATION COMPRISING A MULTIPLE SCLEROSIS AGENT AND AT LEAST ONE ANTI-EPILEPTIC AGENT

Title (en)

A COMBINATION COMPRISING A MULTIPLE SCLEROSIS AGENT AND AT LEAST ONE ANTI-EPILEPTIC AGENT

Title (de)

KOMBINATION MIT EINEM MITTEL GEGEN MULTIPLE SKLEROSE UND MINDESTENS EINEM ANTIEPILEPTIKUM

Title (fr)

COMBINAISON COMPRENANT UN AGENT DE SCLÉROSE EN PLAQUES ET AU MOINS UN AGENT ANTI-ÉPILEPTIQUE

Publication

EP 3893866 A4 20220803 (EN)

Application

EP 19897521 A 20191115

Priority

  • TR 201819197 A 20181212
  • TR 2019050958 W 20191115

Abstract (en)

[origin: WO2020122838A2] The present invention relates to a pharmaceutical combination comprising a multiple sclerosis agent and at least one anti-epileptic agent wherein the multiple sclerosis agent is teriflunomide or fampridine.

IPC 8 full level

A61K 31/197 (2006.01); A61K 9/00 (2006.01); A61K 31/195 (2006.01); A61K 31/277 (2006.01); A61K 31/44 (2006.01); A61K 31/4409 (2006.01); A61K 45/06 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 25/28 (2006.01)

CPC (source: EP)

A61K 31/195 (2013.01); A61K 31/197 (2013.01); A61K 31/277 (2013.01); A61K 31/4409 (2013.01); A61K 45/06 (2013.01); A61P 25/00 (2017.12); A61P 25/08 (2017.12); A61K 9/0053 (2013.01)

C-Set (source: EP)

  1. A61K 31/277 + A61K 2300/00
  2. A61K 31/4409 + A61K 2300/00
  3. A61K 31/195 + A61K 2300/00
  4. A61K 31/197 + A61K 2300/00

Citation (search report)

  • [I] WO 2018082814 A1 20180511 - METRIOPHARM AG [CH]
  • [I] WO 2009126327 A1 20091015 - EPIPHANY BIOSCIENCES INC [US], et al
  • [A] WO 2008157408 A2 20081224 - XENOPORT INC [US], et al
  • [I] ALLINGTON DOUGLAS ET AL: "New approaches in the management of multiple sclerosis", DRUG DESIGN, DEVELOPMENT AND THERAPY, vol. 4, 22 November 2010 (2010-11-22), pages 343 - 366, XP055931883, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998807/pdf/dddt-4-343.pdf> DOI: 10.2147/DDDT.S9331
  • [IY] RAFFEL JOEL ET AL: "Multiple sclerosis", MEDICINE - U K EDITION, THE MEDICINE PUBLISHING COMPANY, GB, vol. 44, no. 9, 29 July 2016 (2016-07-29), pages 537 - 541, XP029683929, ISSN: 1357-3039, DOI: 10.1016/J.MPMED.2016.06.005
  • [Y] ELKJAER M L ET AL: "Teriflunomide for multiple sclerosis in real-world setting", ACTA NEUROLOGICA SCANDINAVICA, MUNKSGAARD, COPENHAGEN, DK, vol. 136, no. 5, 20 March 2017 (2017-03-20), pages 447 - 453, XP071063063, ISSN: 0001-6314, DOI: 10.1111/ANE.12755
  • See references of WO 2020122838A2

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2020122838 A2 20200618; WO 2020122838 A3 20200813; EP 3893866 A2 20211020; EP 3893866 A4 20220803; TR 201819197 A2 20200622

DOCDB simple family (application)

TR 2019050958 W 20191115; EP 19897521 A 20191115; TR 201819197 A 20181212